OLZ alleviated dopamine D2 receptor priming and cognitive impairment and reduced neurotrophins and acetylcholinergic markers produced by D2 receptor priming in the hippocampus (Thacker et al., 2006). The gene discussed is DRD2; the disease is Cognitive impairment.